CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($) $ in Thousands	Total	Series A convertible preferred stock [Member]	Series A-1 convertible preferred stock [Member]	Series B convertible preferred stock [Member]	Preferred Stock [Member] Series A convertible preferred stock [Member]	Preferred Stock [Member] Series A-1 convertible preferred stock [Member]	Preferred Stock [Member] Series B convertible preferred stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022					$ 47,458	$ 4,132	$ 59,855
Beginning balance, Shares at Dec. 31, 2022					2,286,873	312,094	2,625,896
Beginning balance, Shares at Dec. 31, 2022								343,550
Beginning balance at Dec. 31, 2022	$ (130,712)							$ 1	$ 2,625		$ (133,338)
Issuance of common stock from option exercises, Shares								3,575
Issuance of common stock from option exercises	15								15		0
Stock-based compensation expense	296								296		0
Net Income (Loss)	(6,838)										(6,838)
Ending balance, Shares at Mar. 31, 2023					2,286,873	312,094	2,625,896
Ending balance at Mar. 31, 2023					$ 47,458	$ 4,132	$ 59,855
Ending balance, Shares at Mar. 31, 2023								347,125
Ending balance at Mar. 31, 2023	(137,239)							$ 1	2,936		(140,176)
Beginning balance at Dec. 31, 2022					$ 47,458	$ 4,132	$ 59,855
Beginning balance, Shares at Dec. 31, 2022					2,286,873	312,094	2,625,896
Beginning balance, Shares at Dec. 31, 2022								343,550
Beginning balance at Dec. 31, 2022	(130,712)							$ 1	2,625		(133,338)
Other comprehensive loss	0
Net Income (Loss)	(12,645)
Ending balance, Shares at Jun. 30, 2023					2,286,873	312,094	2,625,896
Ending balance at Jun. 30, 2023					$ 47,458	$ 4,132	$ 59,855
Ending balance, Shares at Jun. 30, 2023								349,268
Ending balance at Jun. 30, 2023	(142,721)							$ 1	3,261	$ (145,983)
Beginning balance at Mar. 31, 2023					$ 47,458	$ 4,132	$ 59,855
Beginning balance, Shares at Mar. 31, 2023					2,286,873	312,094	2,625,896
Beginning balance, Shares at Mar. 31, 2023								347,125
Beginning balance at Mar. 31, 2023	(137,239)							$ 1	2,936		(140,176)
Issuance of common stock from option exercises, Shares								2,143
Issuance of common stock from option exercises	15								15
Stock-based compensation expense	310								310
Other comprehensive loss	0
Net Income (Loss)	(5,807)										(5,807)
Ending balance, Shares at Jun. 30, 2023					2,286,873	312,094	2,625,896
Ending balance at Jun. 30, 2023					$ 47,458	$ 4,132	$ 59,855
Ending balance, Shares at Jun. 30, 2023								349,268
Ending balance at Jun. 30, 2023	(142,721)							$ 1	3,261	(145,983)
Beginning balance at Dec. 31, 2023					$ 47,458	$ 4,132	$ 59,855
Beginning balance, Shares at Dec. 31, 2023		2,286,873	312,094	2,625,896	2,286,873	312,094	2,625,896
Beginning balance, Shares at Dec. 31, 2023								359,569
Beginning balance at Dec. 31, 2023	(182,921)							$ 1	4,159		(187,081)
Conversion of convertible preferred stock to common stock in connection with the Merge, Share					(2,286,873)	(312,094)	(2,625,896)	5,224,863
Conversion of convertible preferred stock to common stock in connection with the Merger, Value	111,445				$ (47,458)	$ (4,132)	$ (59,855)	$ 1	111,444
Issuance of common stock in the pre-closing financing, Shares								1,682,045
Issuance of common stock in the pre-closing financing, Value	42,000								42,000
Issuance of common stock for conversion of convertible notes, Shares								1,433,410
Issuance of common stock for conversion of Convertible Notes, Value	22,705								22,705
Issuance of common stock to Homology shareholders in reverse recapitalization, Shares								3,229,633
Issuance of common stock to Homology shareholders in reverse recapitalization, Value	64,292								64,292
Reverse recapitalization transaction costs	(10,013)								(10,013)
Issuance of CVR at fair value	(180)								(180)
Stock-based compensation expense	417								417
Other comprehensive loss	(5)									(5)
Net Income (Loss)	1,029										1,029
Ending balance, Shares at Mar. 31, 2024					0	0	0
Ending balance at Mar. 31, 2024					$ 0	$ 0	$ 0
Ending balance, Shares at Mar. 31, 2024								11,929,520
Ending balance at Mar. 31, 2024	48,769							$ 2	234,824	(5)	(186,052)
Beginning balance at Dec. 31, 2023					$ 47,458	$ 4,132	$ 59,855
Beginning balance, Shares at Dec. 31, 2023		2,286,873	312,094	2,625,896	2,286,873	312,094	2,625,896
Beginning balance, Shares at Dec. 31, 2023								359,569
Beginning balance at Dec. 31, 2023	$ (182,921)							$ 1	4,159		(187,081)
Issuance of common stock from option exercises, Shares	53,077
Other comprehensive loss	$ (1)
Net Income (Loss)	(15,949)
Ending balance, Shares at Jun. 30, 2024		0	0	0	0	0	0
Ending balance at Jun. 30, 2024					$ 0	$ 0	$ 0
Ending balance, Shares at Jun. 30, 2024								11,995,206
Ending balance at Jun. 30, 2024	33,511							$ 2	236,540	(1)	(203,030)
Beginning balance at Mar. 31, 2024					$ 0	$ 0	$ 0
Beginning balance, Shares at Mar. 31, 2024					0	0	0
Beginning balance, Shares at Mar. 31, 2024								11,929,520
Beginning balance at Mar. 31, 2024	48,769							$ 2	234,824	(5)	(186,052)
Issuance of common stock from option exercises, Shares								53,077
Issuance of common stock from option exercises	380								380
Issuance Of Common Stocks From Rsu Vesting, Shares								12,609
Stock-based compensation expense	1,336								1,336
Other comprehensive loss	4									4
Net Income (Loss)	(16,978)										(16,978)
Ending balance, Shares at Jun. 30, 2024		0	0	0	0	0	0
Ending balance at Jun. 30, 2024					$ 0	$ 0	$ 0
Ending balance, Shares at Jun. 30, 2024								11,995,206
Ending balance at Jun. 30, 2024	$ 33,511							$ 2	$ 236,540	$ (1)	$ (203,030)